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ABSTRACT 
Purpose: To systematically assess the literature on psychosocial interventions to 
improve mental health (i.e. depression, anxiety, mental fatigue, loneliness, 
psychological stress and psychological well-being) in visually impaired adults (≥ 18 
years). 
Methods: The databases Medline, Embase and Psychinfo were searched for relevant 
studies, which were categorized into randomised controlled trials (RCTs), non-RCTs 
and before and after comparisons (BA). The Cochrane Collaboration Risk of Bias Tool 
was used to assess study quality. Standardized mean differences (SMD) were calculated 
to quantitatively summarize the outcomes of the RCTs and non-RCTs in a meta-
analysis. Meta-regression was used to explore sources of heterogeneity in the data. 
Results: The search identified 27 papers (published between 1981 and 2015), describing 
the outcomes of 22 different studies (14 RCTs, 4 non-RCTs, and 4 BAs). Pooled 
analyses showed that interventions significantly reduced depressive symptoms (SMD -
0.30, 95% confidence interval (CI) -0.60 to -0.01), while effects on anxiety symptoms, 
mental fatigue, psychological stress and psychological well-being were non-significant. 
Meta-regression analyses showed homogeneity in effect sizes across a range of 
intervention, population, and study characteristics. Only a higher age of participants was 
associated with less effective results on depressive symptoms (b=0.03, 95% CI 0.01 to 
0.05), psychological stress (b=0.07, 95% CI 0.01 to 0.13) and psychological well-being 
(b=-0.03, 95% CI -0.05 to 0.01). However, after removing a clear outlier the overall 
effect on depressive symptoms and  the influence of age on depressive symptoms and 
psychological stress were no longer significant, while the influence of age on 
psychological well-being remained. 
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Conclusions: There is currently only limited evidence for the effectiveness of 
psychosocial interventions in the field of low vision. More well-designed trials are 
needed with specific attention for interventions tailored to the needs of elderly patients.
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INTRODUCTION 
Irreversible vision loss may prevent individuals from their primary means to engage in 
the world and perform valued activities.1,2 This requires significant adaptation, a process 
characterised by mental health problems.3 About one-third of people with visual 
impairment experience subthreshold depression and/or anxiety (indicating subclinical 
symptoms),4-6 5-7% are diagnosed with a major depressive disorder4-6 and 7% with an 
anxiety disorder.4 These percentages are significantly higher than the prevalence in 
normally sighted peers.4 Vision loss is also associated with mental fatigue,1,7 less social 
contact,2,8 and can induce feelings of loneliness and social isolation.2,8 
 The importance of targeted interventions to address mental health problems in 
people with visual impairment is increasingly becoming recognised.9-11 However, 
compared to the large body of research in the general population,12 research on 
psychosocial interventions to improve mental health in people with visual impairment is 
still in its infancy.9-11 Rees et al. (2010)9 and Binns et al. (2012)10 performed a 
systematic review on the effects of multidisciplinary low vision rehabilitation services. 
They concluded that these services may improve aspects of clinical and functional 
ability, however, the effects on mood are less clear, and the number of well-designed 
and adequately reported studies is small. In addition, Holloway et al. (2015)11 performed 
a systematic review and meta-analysis on problem solving interventions to improve 
psychosocial outcomes in people with visual impairment. Based on 8 trials, they showed 
that problem solving interventions can improve vision-related functioning and 
emotional distress. However, no evidence was found to support improvements in 
depressive symptoms. 
 These systematic reviews indicate that the effects of interventions to improve 
mental health in the field of low vision are unclear. However, these reviews have several 
6 
 
important drawbacks: 1) they do not include all types of psychosocial interventions, 
offered in different settings, aimed at increasing mental health in people with visual 
impairment, 2) they do not perform meta-regression analyses to identify sources of 
heterogeneity between the studies, and 3) the systematic reviews of Rees et al. (2010)9 
and Binns et al. (2012)10 need an update on new and current studies in this upcoming 
field. 
Therefore, we believe that it is important to provide a broad up-to-date 
systematic review, based on liberal inclusion criteria, to provide an overall view of the 
studies that are performed in this field. The aim of this study is to systematically review 
quantitative evidence on psychosocial interventions that address mental health problems 
in adults (≥ 18 years) with visual impairment and perform a meta-analysis with meta-
regression. Since multiple studies indicate that visual impairment is associated with 
increased levels of depression,2,4-6 anxiety,2,4 mental fatigue,1,7 loneliness,2,8 
psychological stress,7 and lower psychological well-being,1,7,8 these mental health 
problems were investigated in this study. The information of this review is essential to 
allow a targeted approach to reduce or prevent mental health problems in people with 
visual impairment. 
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METHODS 
Search method 
Potential articles were identified through searches in Medline, Embase and Psychinfo 
from their date of inception until June 3rd 2015, and the reference lists of retrieved 
articles. Other databases were also considered but, as the findings from the three initial 
databases were similar, additional searches were deemed unnecessary. Search syntaxes 
were developed in consultation with an experienced university librarian. A broad range 
of terms were used in the definitions of intervention studies, visual impairment, adults 
and mental health (Appendix 1 presents the full electronic search strategy). Reference 
lists of the retrieved articles were searched by hand to identify additional relevant 
studies. The selection procedure was performed by three researchers (HA, TM and RN) 
and included four stages: 1) reviewing title, 2) reviewing title and abstract, 3) reading 
the full text of the articles, and 4) quality assessment. Discrepancies were resolved by 
discussion.  
 
Study criteria 
The following inclusion criteria were used: 1) original research reported in English, 2) 
longitudinal design with a minimum of two measurement time-points, 3) participants 
were diagnosed with an eye disease as a cause of severe visual impairment, or had low 
vision (visual acuity ≤0.3 or visual field ≤30º), or blindness (visual acuity ≤0.05 or 
visual field ≤10º), 4) participants had a minimum age of 18 years, 5) sample size of ≥ 10 
participants, 6) a psychosocial intervention designed to bring about modification of 
feelings, cognitions, attitudes, and behaviours was investigated, 7) the intervention was 
aimed at reducing mental health problems, 8) outcome measures on depression, anxiety, 
mental fatigue, loneliness, psychological stress, psychological well-being were reported. 
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Data extraction 
The following general characteristics of the studies were extracted: 1) country and year 
of publication, 2) study design and measurement time-points, 4) sample information (i.e. 
mean age, proportion of women, visual impairment, sample size at baseline and drop-
out rate), 5) outcome measures, 6) setting, 7) intervention, and 8) control condition.  
 
Quality assessment  
Randomised controlled trials (RCT), non-RCTs and before and after comparisons (BA) 
were distinguished. For quality assessment of these studies the Cochrane Collaboration 
Risk of Bias Tool (CCRBT) was used by two of the three researchers who also 
performed the selection procedure (HA and TM). This tool considers seven parameters: 
1) random sequence generation (selection bias), 2) allocation concealment (selection 
bias), 3) blinding of participants and staff (performance bias), 4) blinding of outcome 
assessment (detection bias), 5) incomplete outcome data addressed (attrition bias), 6) 
selective outcome reporting (reporting bias), and 7) other bias.13 Each parameter was 
rated as low risk, high risk or unclear risk (Appendix 2). For non-RCTs and BAs, 
parameters 1 to 3 were not rated because those study designs do not allow to meet these 
requirements. Discrepancies were resolved by discussion or by consulting another 
review author. 
 
Synthesis of evidence 
Because BAs preclude comparison of groups, a narrative method was used to synthesize 
evidence from these studies, taking study quality into account. For the RCTs and non-
RCTs both a narrative and quantitative pooling method was used. Standardised mean 
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differences (SMD) for the total follow-up were determined to facilitate comparisons 
between different continuous scales that were used to determine mental health 
outcomes. Cohen's categories for classifying effect sizes were used: 0.2 represents a 
small effect, 0.5 a medium effect, and ≥0.8 a large effect.14 For each outcome the 
number of participants, mean change from baseline to follow-up and the standard 
deviation (SD) of these mean changes were extracted for the intervention and control 
group separately. In some cases the SD was derived from the standard error (SE), p-
value, 95% confidence interval or other methods that are recommended by the Cochrane 
collaboration. If these parameters were not available, the authors were contacted by e-
mail and asked to provide these data. Differences in change scores between the groups 
were divided by the SD of change, leading to an effect size (SMD) that allowed 
different studies to be pooled and compared. SMDs and 95% confidence intervals (CI) 
were reported. Before combining the data, statistical heterogeneity was assessed, using 
the I² test describing the percentage of variation between studies based on heterogeneity 
rather than on chance. Substantial heterogeneity (I² > 50%) was detected, therefore, the 
results were combined in a meta-analysis using the random-effects model. Forest plots 
were provided to graphically display the estimated results, in which squares were 
provided that are proportional to the study's weight in the meta-analysis. In addition, 
meta-regression analyses were performed to explore sources of heterogeneity in the data 
in terms of study characteristics (i.e. year of publication, drop-out rates, risk of bias, 
study design: RCT vs. non-RCT), population characteristics (i.e. mean age of 
participants, percentage of females, people with specific eye diseases versus people with 
low vision or blindness in a range of eye conditions with different causes), 
characteristics of the intervention (i.e. individually or group-based interventions, setting: 
within low vision rehabilitation, at home or within a clinic/hospital), and characteristics 
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of the control condition (no intervention versus usual care/comparable intervention).To 
visualise the relationship between factors used in the meta-regression and the study 
outcomes, SMD bubble plots were used. Funnel plots (scatterplots of treatment effects 
against a measure of study size) were used to assess publication bias if enough studies 
were found to use this analysis. In the absence of publication bias points were 
symmetrical about the vertical line of this plot. 
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RESULTS 
Database search 
The initial search identified 3,512 articles (Figure 1). After screening the titles and 
abstracts, 73 articles remained for which the inclusion and exclusion criteria were 
screened; this resulted in 27 articles describing 22 different studies (14 RCTs, 4 non-
RCTs and 4 BAs) that were included in this review. Multiple articles describing 
different outcomes of the same study were jointly reviewed (Table 1).15-23 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Additional articles identified 
through searches in reference 
lists (n=5) 
Articles identified through 
database searches (n=3,507)  Medline (n=1,274)  Embase (n=2,114)  Psychinfo (n=119) 
 
Articles identified after removing 
duplicates (n=3,298) 
Excluded based on title and 
abstract review (n=3,225) 
 
Articles identified after screening on 
title and abstract (n=73) 
Excluded based on in-
/exclusion criteria (n=44)  No original research in English 
(n=4)  Not longitudinal (n=5)  Sample not visually impaired or 
>18 years (n=3)  Sample size <10 (n=2)  No mental health outcome (n=9)  Not a psychosocial intervention 
aimed at improving mental 
health (n=23) 
 
Articles identified after assessing 
eligibility (n=27) 
Studies included in qualitative synthesis 
(n=22) 
Studies included in quantitative 
synthesis (n=18) 
Excluded because  only one 
group was investigated over 
time (n=4) 
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Figure 1. Flow-diagram of study inclusion process 
 
Study characteristics  
The 22 included studies included 2,092 participants, with sample sizes ranging from 12 
participants25 to 252 participants.18 The total period of follow-up ranged from 1 month26 
to 11 months,24 drop-out ranged from 0%20,21,25-28 to 57%,29 mean age ranged from 38 
years22,23 to 84 years30 and 10%20,21 to 79%33 were female (Table 1). In almost half of 
the studies15-19,25,30-35 the participants were diagnosed with age-related macular 
degeneration (AMD), in 6 studies24,36-40  patients had vision impairment (indicating that 
participants had different eye conditions), in two studies20,21,26 patients were blind, in 
two studies27,41 patients were diagnosed with glaucoma, in two studies22,23,28  patients 
had diabetic retinopathy, and in one study29 patients were diagnosed with Stargardt’s 
disease. Half of the studies were performed in the Unites States of America,15-23,28-32,34,37 
one in Australia,36 seven in Europe (i.e. United Kingdom,25,39,40 Germany33,35,41 and the 
Netherlands24) and three in Asian countries (i.e. Iran,26 China27and Japan38). Eighteen 
out of the 22 included studies were conducted in the last decade.15,16,18,19,24-27,29-33,36-40 
 
Patient reported outcomes 
Table 1 provides an overview of the questionnaires that were used to measure mental 
health. The Profile of Mood States (POMS) was used in two studies34,38 to measure 
depressive symptoms, tension/anxiety symptoms, and mental fatigue. The Depression 
Anxiety Stress Scale (DASS) was used in two studies26,36 to measure depressive 
symptoms, anxiety symptoms and psychological stress. The subscales of the POMS and 
DASS show high reliability and internal validity in adults in general.42-44 The Geriatric 
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Depression Scale (GDS) was used in three studies,32,33,35 the Patient Health 
Questionnaire (PHQ)-9 was used in two studies,30,31 the Centre for Epidemiologic 
Studies Depression scale (CES-D) was used in one study,29 the Beck Depression 
Inventory (BDI) was used in one study,28 and the Hamilton rating scale for Depression 
(HAMD) was used in one study15 to measure symptoms of depression. These 
questionnaires all show good reliability and internal validity in adults in general,45-50 
however, only the PHQ-9 was validated in a visually impaired sample.49 Based on cut-
off scores, the PHQ-9 was used in one study30 and the HAMD in another15,16 to 
determine DSM-IV major and minor depressive disorder. These dichotomous outcomes 
could not be incorporated in the meta-analysis, instead, we only used the continuous 
scales of these outcome measures that were also provided by the authors. 
  The Self-rating Depression Scale (SDS) was used in two studies,22,23,27 and the 
Self rating Anxiety Scale (SAS) was used in one study27 to determine depressive and 
anxiety symptomatology. The Wakefield self-rating depression scale and the University 
of California Los Angeles (UCLA) Loneliness scale was used in one study20 to 
determine depressive symptomatology and loneliness, respectively. The reliability and 
validity of these scales are less well established, i.e. outdated methods were used to 
determine psychometric properties.51-53 
  For psychological stress, the Perceived Stress Scale (PSS)-14 was used in one 
study.29 This scale shows good reliability and internal validity,54 however, the 10-item 
PSS was found to be superior to the 14-item PSS.51 In addition, the Problem Areas in 
Diabetes survey (PAID) was used in one study28 to determine diabetes-related stress 
which is a reliable and valid instrument.55  
 Psychological well-being was mostly determined with a mental health subscale 
of vision-related quality of life questionnaires: four studies15,29-31 used the ‘mental 
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health’ subscale of the National Eye Institute Visual Functioning Questionnaire (NEI-
VFQ), one study36 used the ‘emotional well-being’ subscale of the Impact of Visual 
Impairment scale (IVI), and one study40 used the ‘mental health’ subscale of the Vision 
Quality of Life Core Measure (VCM1). These subscales show good reliability and 
validity in a visually impaired sample.56-58 In addition, several mental health subscales 
of health-related quality of life questionnaires were used: two studies24,32 used the 
‘mental health’ subscale of the Short Form Health Survey (SF-36) and the Research and 
Development scale (RAND-36), which are well-established and reliable tools in adults 
in general,59 one study25used the ‘negative well-being’ subscale of the Well-Being 
Questionnaire (WB-Q), which shows good reliability and validity in people with 
macular disease,60 and another study39 used the ‘psychosocial well-being’ subscale of 
the  CORE outcome measure, which shows good reliability and internal validity in the 
general population.61 The Symptom Checklist (SCL) was used by one study27 and the 
Kurzfragebogen zur Aktuellen Beanspruchung (KAB) by another study41 to determine 
psychological problems/strain. For these two questionnaires psychometric properties are 
unclear. 
 
Interventions and their effectiveness 
Eight studies15,16,22,23,27,29-31,37,39  were aimed at investigating the effectiveness of 
individually offered interventions, and twelve studies17-21,24-26,28,32-36,38,40,41 investigated 
group-based interventions (Table 1). Several group-based self-management programmes 
were tested, with core elements of teaching problem solving skills to help patients deal 
with limitations brought on by vision loss. In two RCTs in AMD patients conducted by 
Brody et al. (1999)34 (n=92) and Brody et al.(2002, 2005)17,18 (n=252) showed that this 
type of intervention is effective in reducing psychological distress compared with 
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controls, and that effects on depressive symptoms were strongest for a subgroup of 
patients (n=32) who were clinically depressed at baseline.19 In two pilot studies in AMD 
patients conducted by Birk et al. (2004)35 (n=22) and Wahl et al. (2006)33 (n=24) these 
outcomes were confirmed but the beneficial effects deteriorated over time. In addition, 
in ninestudies24,26,28,30-32,36,38,39 interventions were offered at low vision rehabilitation 
organisations. Of  these, two RCTs investigated the effectiveness of a group-based self-
management programme showing different results: Girdler et al. (2010)32 found a 
significant reduction in symptoms of depression in AMD patients (n=77) in favour of 
the intervention group, while Rees et al. (2015)36 found no effective results in favour of 
the intervention group in increasing emotional well-being in patients with multiple eye 
conditions (n=153). In addition, in an RCT by Rovner et al. (2014)30 beneficial results in 
AMD patients (n=188) for individually offered behavioural activation embedded in low 
vision rehabilitation care was found. Two other RCTs by Rovner et al. (2007, 2008)15,16 
and Rovner et al. (2013)31  (n=206 and n=241, respectively) showed mixed results on 
the effectiveness of problem solving treatment (PST) on reducing depressive symptoms 
in AMD patients. Mixed results were also found by two smaller RCTs conducted by 
Bradley et al. (2005)25 (n=12) and Evans et al. (1981, 1982)20,21 (n=84) and one BA 
conducted by Latham et al. (2013)40 (n=29) on the effectiveness of peer support to 
increase psychological well-being in visually impaired persons. Favourable results were 
found in single RCTs for group-based rational emotive therapy for patients with late 
blindness (n=60),26 and an expressive writing intervention for patients with Stargardt’s 
disease (n=81).29 
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Table 1. Characteristics of reviewed studies in order of publication year, divided into: 1) randomised controlled trials, 2) non-
randomised controlled trials, and 3) before and after comparisons 
Author (year, 
country) 
Study design 
(follow-up) 
Sample: mean age, 
% female, vision 
impairment, 
sample size, % 
drop-out 
Primary and secondary outcome 
measures 
Setting Intervention‡ Control 
1. Randomised controlled trials:      
Rees et al. 
(2015, 
Australia)36 
2-Arm RCT (6 
months) 
80 years, 60% 
female, visual 
impairment, n=153, 
16% drop-out 
 
Of interest: depressive symptoms, 
anxiety symptoms, and stress 
(DASS), emotional wellbeing 
(subscale IVI). Other outcomes: 
self-efficacy (GSES), adaptation to 
vision loss (AVL), vision-related 
quality of life (IVI)  
 LVR Group-based self-management programme: 
coping with illness and disability, techniques 
from adult learning, group processes, and 
cognitive-behavioural approaches (weekly 3-
hour sessions, during 8 weeks, offered by two 
low vision rehabilitation counsellors and guest 
speakers) 
Usual care 
Bryan et al. 
(2014,USA)29 
2-Arm RCT (7 
weeks) 
42 years, 69% 
female, Stargardt’s 
disease (juvenile 
form of AMD), 
Of interest: depressive symptoms 
(CES-D), perceived stress (PSS), 
mental health (subscale NEI-VFQ). 
Other outcomes: social support, 
Patients’ homes Expressive writing intervention: expressing 
emotions through written disclosure of a post 
traumatic experience (for 20 minutes on three 
separate days, during a 1-week period, 
Neutral writing 
intervention 
(similar in dose 
and intensity) 
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n=81, 57% drop-out physical symptoms, vision-related 
quality of life (NEI-VFQ) 
participants were instructed by the researchers) 
Jalali et al. 
(2014, Iran)26 
2-Arm RCT (1 
month) 
20-40 years, gender 
not reported, blind, 
n=60, no drop-out 
Of interest: depressive symptoms, 
anxiety symptoms, stress (DASS). 
Other outcomes: beliefs (Jones 
irrational beliefs questionnaire), 
self-esteem (Eysenck’s self-esteem 
inventory) 
LVR Group-based rational emotive behavioural 
therapy: a comprehensive, active-directive 
psychotherapy which focuses on resolving 
emotional and behavioural problems (number 
of sessions and duration is unclear, offered by 
therapists of whom background is unclear) 
No training 
Rovner et al. 
(2014,USA)30 
2-Arm RCT (4 
months) 
84 years, 70% 
female, AMD, 
n=188, 10% drop-
out 
Of interest: depressive disorder 
(PHQ), mental health (subscale 
NEI-VFQ). Other outcomes: vision 
status, functional vision, physical 
health status, personality, 
behavioural activation, device use, 
vision-related quality of life (NEI-
VFQ),  
LVR Behavioural activation: functional analytic 
psychotherapy which focusses on targeting 
behaviours that might maintain/worsen 
depression (6 in home 1-hour sessions, offered 
by 1 of 5 occupational therapists) + LVR  
Supportive 
therapy (similar 
in dose and 
intensity) + LVR 
Rovner et al. 
(2013, USA)31 
2-Arm RCT (6 
months) 
82 years, 64% 
female, AMD, 
n=241, 11% drop-
out 
Of interest: depressive disorder 
(PHQ), mental health (subscale 
NEI-VFQ). Other outcomes: 
targeted vision function, control 
LVR Problem Solving Treatment: cognitive–
behavioural intervention with a positive goal-
oriented approach (mean of 6 sessions, 45-60 
minutes per session, offered by trained bachelor 
Supportive 
therapy (similar 
in dose and 
intensity) 
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strategies, activity inventory, 
physical health status, vision-
related quality of life (NEI-VFQ) 
or master-level therapists) 
Sun et al. 
(2012, China)27 
2-Arm RCT (6 
months) 
62 years, gender not 
reported, glaucoma, 
n=100, no drop-out 
Of interest: depressive symptoms 
(SDS), anxiety symptoms (SAS), 
psychological problems (SCL) 
Clinical setting/ 
hospital 
Psychological therapy: specific content unclear 
(during 6 months, number of sessions unclear, 
provided by psychiatrists and specialist nurses) 
+ physical therapy 
Physical therapy; 
specific content 
unclear (during 
six months) 
Girdler et al. 
(2010, USA)32 
2-Arm RCT (12 
weeks) 
79 years, 65% 
female, AMD, 
n=77, 3% drop-out 
Of interest: depressive symptoms 
(GDS), mental health (subscale 
SF36). Other outcomes: 
participation (ACS), adaptation to 
vision loss (AVL), self-efficacy 
(GSES, AMD-SEQ) 
LVR Group-based vision self-management 
programme: problem solving based on self-
efficacy and group model of service delivery 
principles (weekly structured programme, 
during 8 weeks, led by an occupational 
therapist and a social worker) + usual care 
Usual care  
Rovner et al. 
(2007, 2008, 
USA)15,16 † 
2-Arm RCT (6 
months) 
81 years, 70% 
female, AMD, 
n=206, 8% drop-out 
Of interest: depressive symptoms 
(HAMD), DSM-IV major and 
minor depressive disorder 
(Schedule for Affective Disorders 
and Schizophrenia and the HAMD), 
mental health (subscale NEI-VFQ). 
Other outcomes: visual acuity, 
Patients’ homes Problem Solving Treatment: cognitive–
behavioural intervention with a positive goal-
oriented approach (6 in-home sessions, 45-60 
minutes per session, during 8 weeks, provided 
by 2 nurses and 1 master’s-level counsellor)  + 
usual care 
Usual care 
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contrast sensitivity, vision-related 
quality of life (NEI-VFQ). 
Goldstein et al. 
(2007, USA)37 
2-Arm RCT (3 
months) 
78 years, 64% 
female, visual 
impairment, n=154, 
3% drop-out 
Of interest: emotional well-
being/response (5 questions on a 4-
point Likert scale on experiencing 
fear, sadness, frustration, 
hopefulness and peacefulness). 
Other outcomes: knowledge, 
adaptive behaviour, self-efficacy 
(AMD-SEQ). 
Patients’ homes Educational video: incorporating cognitive 
restructuring to change emotional response with 
a focus on increasing knowledge and awareness 
(participants watched the video at home within 
2 weeks, no additional support was provided). 
Waiting list 
Wahl et al. 
(2006, 
Germany)33 
3-Arm pilot 
non-RCT (3 
months) 
77 years, 79% 
female, AMD, n=45 
(randomised in two 
intervention arms), 
n=24 (self-selected 
comparison group), 
22% drop-out 
Of interest: depressive symptoms 
(GDS). Other outcomes: coping, 
adaptation to vision loss (AVL) 
Clinical setting/ 
hospital 
Group-based psychological intervention with 
an emphasis on cognitive behavioural therapy, 
investigated in two separate arms: 
1. emotion focused to increase coping strategies 
2. problem focused to develop solutions for 
behavioural consequences of AMD 
(3 sessions of 2 to 3 hours, over a three week 
period, offered as part of an eye clinic’s 
treatment programme) 
No intervention 
(control group not 
randomised) 
Brody et al. 3-Arm RCT (6 81 years, 67% Of interest: psychological distress Clinical setting/ Group-based self-management programme: Educational tape 
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(2002, 2005, 
2006, USA)17-19 
† 
months) female, AMD, 
n=252 (subgroup 
analysis 2006 
n=32), 15% drop-
out (2005) 
(POMS total score), depressive 
symptoms (GDS). Other outcomes: 
self-efficacy (AMD-SEQ) 
hospital didactic presentation and group problem 
solving with guidance (weekly 2-hour sessions 
for 6 weeks, led by an experienced professional 
in public health and behavioural medicine) 
intervention 
(2002) and 
waiting list (2005, 
2006) 
Bradley et al. 
(2005, UK)25 
2-Arm pilot 
RCT (6 weeks) 
76 years, 50% 
female, MD, n=12, 
no drop-out 
Of interest: negative well-being 
(W-BQ). Other outcomes: MD-
related quality of life (MacDQol) 
Clinical setting/ 
hospital 
Group-based peer support and information 
provision: discussion groups were organised 
and 6 leaflets with information were distributed 
(6 weekly sessions of 1.5-hour, led by people 
experienced in living with MD) 
Treatment 
delayed for 6 
weeks 
Brody et al. 
(1999, USA)34 
2-Arm RCT (6 
weeks) 
79 years, 50% 
female, AMD, 
n=92, 41% drop-out 
Of interest: depressive symptoms, 
anxiety symptoms and mental 
fatigue (POMS). Other outcomes: 
self-efficacy (AMD-SEQ). 
 
Clinical setting/ 
hospital 
Group-based self-management programme: 
guided through a hierarchy of behavioural 
challenges to improve problem-solving 
techniques (weekly 2-hour sessions for 6 
weeks, guided by peers and professionals 
whose background was not reported) 
Waiting list 
Kaluza et al. 
(1996, 
Germany)41 
2-Arm RCT (8 
weeks) 
52 years, 78% 
female, open angle 
glaucoma, n=23, 
13% drop-out 
Of interest: psychological strain 
(KAB). Other outcomes: 
intraocular pressure, heartbeat. 
Clinical setting/ 
hospital 
Group-based relaxation training: performing 
autogenic relaxation exercises with peers and at 
home (weekly 1.5-hour session, during 8 
weeks, provided by an experienced clinical 
Waiting list 
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psychologist) 
2. Non-randomised controlled trials     
Ueda et al. 
(2013, Japan)38 
3-Arm non-
RCT(6 months) 
46 years, 32% 
female, visual 
impairment, n=79, 
drop-out not 
reported 
Of interest: depressive symptoms, 
anxiety symptoms and mental 
fatigue (POMS). Other outcomes: 
psychological adjustment to vision 
loss, self-efficacy (Nottingham 
adjustment to vision loss scale) 
LVR 1. First arm received skills training, aimed at 
improving skills on orientation, mobility, 
activities of daily living), and group 
counselling, aimed at sharing experiences, 
psycho-education, and stress reduction 
techniques (weekly 1.5-hour sessions, during 
10 weeks, guided by a clinical psychologist) 
2. Second arm received the same skills training, 
and group counselling and additionally received 
individual counselling based on cognitive 
behavioural  therapy (weekly for 45 minutes, 
during 10 weeks, provided by a clinical 
psychologist) 
Skills training 
(similar in dose 
and intensity) 
Birk et al. 
(2004, 
Germany)35 
2-Arm pilot 
non-RCT (8 
weeks) 
73 years, 64% 
female, AMD, 
n=22, 36% drop-
out. 
Of interest: depressive symptoms 
(GDS). Other outcomes: positive 
and negative affect, coping style. 
Clinical setting/ 
hospital 
Group-based psychological intervention: 
exchange of information and experiences, 
muscle relaxation, increasing problem-solving 
skills, and an emphasis on cognitive 
behavioural therapy (weekly 1-hour sessions, 
Usual care 
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during 5 weeks, offered by two group trainers 
with a background in clinical psychology) 
Trozzolino et 
al. (2003, 
USA)28 
2-Arm non-
RCT (12 weeks) 
63 years, 65% 
female, diabetes 
retinopathy, n=48, 
no drop-out 
Of interest: depressive symptoms 
(BDI), diabetes related 
psychological stress (PAID). Other 
outcomes: diabetes knowledge, 
serum glycosylated haemoglobin 
(HbA1c). 
 LVR Group-based psycho-educational therapy: based 
on cognitive behavioural therapy aimed at 
increasing adherence to a diabetes regime and 
decreasing mental health problems (weekly 
sessions, during 12 weeks, offered by LVR 
professional) + optometric and rehabilitation 
training 
Optometric and 
rehabilitation 
training (i.e. 
device use) 
Evans et al. 
(1981, 1982, 
USA)20,21 † 
2-Arm non-
RCT (8 weeks) 
62 years, 10% 
female, blind 
veterans, n=84, no 
drop-out 
Of interest: depressive symptoms 
(Wakefield self-rating depression 
scale), loneliness (UCLA loneliness 
scale) 
Patients’ homes Group by telephone programme: telephone 
meetings with a group of peers using cognitive 
behavioural techniques (weekly 1-hour 
telephone meeting, during 8 weeks, guided by a 
counsellor) 
No intervention 
3. Before and after comparisons      
Barr et al. 
(2014, UK)39 
1-Arm pilot BA 
(1 to 46 week ) 
59 years, 66% 
female, visual 
impairment, n=64, 
45% drop-out  
Of interest: psychosocial well-being 
(CORE outcome measure) 
LVR Counselling and emotional support (no specific 
model) aimed at exploring thoughts and 
feelings about the impact of visual impairment, 
reflecting on beliefs, and identifying personal 
strengths (a maximum of 12 sessions for 50 
No control group 
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minutes each, offered by experienced 
counsellors) 
Latham et al. 
(2013, UK)40 
1-Arm BA (6 
months) 
54 years, 45% 
female, visual 
impairment, n=29, 
drop-out not 
reported 
Of interest: mental health (subscale 
VCM). Other outcomes: vision-
related quality of life (VCM) 
Clinical setting/ 
hospital 
Group-based emotional peer support service 
and telephone support: share fears and 
experiences that encourage a problem-solving 
approach (6 to 8 weekly sessions of 3 hours 
each, and telephone support once a month for 6 
months after completion of the sessions, offered 
by trained and experienced staff) 
No control group 
Alma et al. 
(2013, The 
Netherlands)24 
1-Arm BA (11 
months) 
73 years, 69% 
female, visual 
impairment, n=29, 
10% drop-out 
Of interest: emotional well-being 
(subscale of the RAND-36) 
Other outcomes: adaptation to 
vision loss (AVL), helplessness 
(subscale ICQ), generic and vision-
specific fear of falling. 
LVR Group-based rehabilitation programme: 
promote adaptation and psychosocial 
functioning by training practical skills, social 
interacting, problem solving, goal setting, and 
home-based exercises (20 weekly 2-hour 
sessions, and a booster session, offered by two 
trained occupational therapists) 
No control group 
Bernbaum et al. 
(1988, 1989 
USA)22,23 † 
1-Arm BA (12 
weeks) 
38 years, 62% 
female, diabetic 
retinopathy, divided 
in two group: stable 
Of interest: depressive symptoms 
(SDS), mental health (Rand Mental 
Health Index). Other outcomes: 
glucose control, body weight, 
Fitness Centre Rehabilitation programme: diabetes education, 
exercise programme, individually and group-
based counselling (three times a week for 12 
weeks, offered by a trained multidisciplinary 
No control group 
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or transitional 
vision (1988) and 
insulin-dependent 
and independent 
(1989), n=29, 10% 
drop-out 
diabetes knowledge, self-esteem 
(Rosenberg self-esteem scale) 
team of specialists and psychologists) 
 
† Articles were jointly reviewed, because they were based on the same study.  
‡ Individually offered unless stated otherwise. 
LVR low vision rehabilitation, RCT randomised Controlled Trial, DASS Inventory Depression Anxiety Stress, GSES Generalised Self-Efficacy Scale, AVL Adaptation to Vision Loss scale, 
IVI Impact of Visual Impairment, USA United States of America, AMD Age-related Macular Degeneration, NEI-VFQ National Eye Institute Visual Functioning Questionnaire, PSS 
Perceived Stress Scale, CES-D Center for Epidemiologic Studies Depression scale, PHQ Patient Health Questionnaire, GDS Geriatric Depression Scale, SWL Satisfaction with Life scale, 
SCL Symptom Checklist, SDS self-rating depression scale, SAS self-rating anxiety scale, HAMD Hamilton rating scale for depression, HAM-A Hamilton rating scale for anxiety, ACS 
Activity Card Sort, SF36 Short Form Health Survey, AMD-SEQ Age-related Macular Degeneration Self-Efficacy Questionnaire, POMS Profile of Mood States, UK United Kingdom, MD 
Macular Degeneration, W-BQ Well-Being Questionnaire, MacDQol Macular disease Dependent Quality of Life, KAB Kurzfragebogen zur Aktuellen Beanspruchung, BDI Beck Depression 
Inventory, PAID Problem Areas in Diabetes survey, UCLA University of California Los Angeles, VCM Vision Quality of Life Core Measure, ICQ Illness Cognition Questionnaire, RAND 
Research and Development 
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Quality assessment 
Most RCTs15-19,29-32,36,37 had a low risk of selection bias because proper randomisation 
methods were used, however, in several studies25-27,34,41 this was not reported adequately 
and in one study33 this was rated as a high risk because sequence generation was unclear 
and one of the comparison groups was not randomised (Table 2). Due to the nature of 
the interventions all RCTs used a pragmatic design in which blinding of participants and 
staff was not possible. The risk of detection bias in the RCTs was mostly rated as low 
because assessors were masked.15-19,29-33,36 One RCT37 was assessed as having a high 
risk of detection bias because interviewers were not blinded. In addition, the non-RCTs 
and BAs were mostly rated as having a high risk of detection bias, because the chosen 
design complicated the possibility of blinding interviewers.22-24,35,39,40 The risk of 
attrition bias for most RCTs15-19,25-27,30-32,36,37 was rated as low (i.e. drop-out was low, 
intention-to-treat analyses were performed, missing data were not related to the outcome 
or significantly different between treatment arms). Three RCTs29,34,41 were assessed as 
having a high risk of attrition bias because of high drop-out rates or per protocol 
analyses. For the non-RTCs and BAs the assessments on attrition bias were mixed: five 
studies were rated as having a low risk,20-23,24,28,40 whereas three were rated as having a 
high risk of attrition bias.35,38,39 Risk of reporting bias was often unclear because trial 
registrations and/or study protocols were not available. Only Rovner et al. (2014)30 and 
Rovner et al. (2013)31 provided sufficient information to assess a low risk of reporting 
bias (i.e. they performed their study as described in the study protocol). Risk of other 
types of bias was rated as high for all BAs for various reasons, mostly related to the 
chosen design (e.g. possible confounding).22-24,39,40 For the RCTs and non-RCTs these 
assessments were mixed. Fidelity to the treatment protocol was often not reported.
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Table 2. Quality assessment based on the Cochrane Collaboration Risk of Bias Tool (low, high or unclear risk) 
Author (year, 
country) 
Random 
sequence 
generation: 
Selection bias 
Allocation 
concealment: 
Selection bias 
Blinding of 
participants and 
professionals: 
Performance 
bias 
Blinding of 
outcome 
assessment: 
Detection bias 
Incomplete 
outcome data:  
Attrition bias 
Selective 
reporting : 
Reporting bias 
 
 
Other bias 
1. Randomised controlled trials:       
Rees et al. (2015, 
Australia)36 
Low: computer 
generated random 
allocation 
Low: sealed 
envelopes 
High: blinding 
impossible due to 
the nature of the 
intervention 
Low: independent 
research assistants 
were masked  
Low: intention-
to-treat analysis, 
low drop-out 
(16%) 
Unclear: trial 
was registered 
retrospectively, 
timing of 
reported 
outcomes does 
not match 
protocol 
Unclear: no difference 
between responders and non-
responders, adjusted for (few) 
baseline differences, only 
17.9% of those eligible 
volunteered (possible 
selection bias), lack of 
objective fidelity checks. 
Bryan et al. (2014, 
USA)29 
Low: random 
number generator 
Unclear: not 
reported 
High: blinding 
impossible due to 
the nature of the 
intervention 
Low: outcomes 
obtained 
electronically 
directly from 
patients 
High: high 
drop-out (57%), 
no sample size 
calculation, low 
power 
Unclear: 
protocol not 
available 
Unclear: no baseline 
imbalances, those who 
dropped-out were more 
depressed and stressed at 
baseline, no information on 
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treatment fidelity is provided 
Jalali et al. (2014, 
Iran)26 
Unclear: not 
reported 
Unclear: not 
reported 
High: blinding 
impossible due to 
the nature of the 
intervention 
Unclear: 
outcomes 
obtained in 
groups, masking 
of interviewers 
not reported 
Low: 100% of 
those enrolled 
completed the 
final outcome 
Unclear: 
protocol not 
available 
High: possible selection bias, 
baseline characteristics not 
reported, pre-test and follow-
up not directly compared, no 
information on treatment 
fidelity 
Rovner et al. 
(2014,USA)30 
Low: random 
numbers table 
Low: sealed 
envelopes 
High: blinding 
impossible due to 
the nature of the 
intervention 
Low: research 
assistants were 
masked 
Low: low drop-
out (10%), high 
power 
Low: trial 
registration and 
protocol 
available 
Low: small baseline 
imbalances, no differences 
found between responders 
and non-responders, treatment 
fidelity maintained 
Rovner et al. (2013, 
USA)31 
Low: random 
number table with 
block design 
Low: serially 
numbered, 
sealed 
envelopes 
High: blinding 
impossible due to 
the nature of the 
intervention 
Low: independent 
nurse was 
masked, only a 
small number of 
participants 
revealed 
allocation 
Low: low drop-
out (11%), 
enough power, 
intention-to-
treat analysis 
Low: protocol 
available, some 
outcomes not 
(yet) reported  
Low: no baseline imbalances, 
treatment fidelity maintained 
Sun et al. (2012, Unclear: not Unclear: not High: blinding Unclear: not Low: 100% of Unclear: Unclear: no information on 
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China)27 reported reported impossible due to 
the nature of the 
intervention 
reported those enrolled 
provided 
outcome data 
protocol not 
available 
baseline imbalances and 
treatment fidelity is provided 
Girdler et al. (2010, 
USA)32 
Low: computer 
generated random 
allocation 
Unclear: not 
reported 
High: blinding 
impossible due to 
the nature of the 
intervention 
Low: assessor was 
masked, authors 
reported possible 
allocation 
disclosure 
Low: intention-
to-treat analysis, 
no drop-out 
Unclear: no 
protocol 
available, only 
pilot study 
Unclear: no baseline 
imbalances, however, 
probable selection bias and 
unclear if mixed-method 
analyses were used, treatment 
fidelity maintained 
Rovner et al. (2007, 
2008, USA)15,16 † 
Low: fixed table, 
block design 
Low: sealed 
envelopes 
High: blinding 
impossible due to 
the nature of the 
intervention 
Low: assessors 
were masked, 
18% of 
participants 
revealed 
allocation, 
however, no 
difference in 
depression found 
indicating no 
significant bias 
Low: low drop-
out (8%), 
intention-to-
treat analysis, 
sample size 
calculation not 
reported 
Unclear: trial 
registration, 
however, 12 
months follow-
up not reported 
Low: no baseline imbalances, 
treatment fidelity maintained 
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Goldstein et al. 
(2007, USA)37 
Low: randomized 
block design 
Low: software 
assigned 
participants 
High: blinding 
impossible due to 
the nature of the 
intervention 
High: survey staff 
was not blinded 
Low: enough 
power, low 
drop-out 
Unclear: trial 
registration and 
protocol not 
available 
Unclear: no baseline 
imbalances, however, drop-
out analyses not performed 
and no information on 
treatment fidelity 
Wahl et al. (2006, 
Germany)33 
High: unclear 
sequence 
generation, 
control group not 
randomised 
Unclear: not 
reported 
High: blinding 
impossible due to 
the nature of the 
intervention 
Low: interviewers 
were masked 
Unclear: no 
differences in 
responders and 
non-responders, 
however, low 
sample size, low 
power 
Unclear: trial 
registration and 
protocol not 
available 
Unclear: unclear when post-
assessment took place, if 
baseline differences were 
statistically significant, and 
no information on treatment 
fidelity 
Brody et al. (2002, 
2005, 2006, 
USA)17-19 † 
Low: computer 
generated random 
allocation 
Low: 
sequentially 
numbered, 
sealed 
envelopes 
High: blinding 
impossible due to 
the nature of the 
intervention 
Low: procedures 
to keep treatment 
allocation 
unknown 
to the interviewers 
(psychologists, 
researchers) 
Low: no 
missing data, 
drop out only 
15% and not 
related to 
treatment 
allocation 
(2002, 2005). 
Unclear: trial 
registration and 
protocol not 
available 
Unclear: no baseline 
imbalances, however, it is 
unclear if controls (taken 
together) crossed over to 
treatment before 6 month 
evaluation (2005 and 2006) 
and if treatment fidelity was 
maintained 
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Subgroup 
analyses not 
enough power 
(2006) 
Bradley et al. 
(2005, UK)25 
Unclear: not 
reported 
Unclear: not 
reported 
High: blinding 
impossible due to 
the nature of the 
intervention 
Unclear: not 
reported 
Low: no drop-
out 
Unclear: trial 
registration and 
protocol not 
available 
Unclear: no baseline 
imbalances, however, small 
sample size and treatment 
fidelity not reported 
Brody et al. (1999, 
USA)34 
Unclear: 
insufficient 
information, 
not clear how 
randomization 
was performed 
Unclear: 
insufficient 
information 
High: blinding 
impossible due to 
the nature of the 
intervention 
Unclear: assessor 
not reported. 
High: per 
protocol 
analyses, 
intention-to-
treat not 
reported, 
inadequate 
power with 
n=54 instead of 
n=102.  
Unclear: some 
outcomes not 
reported 
 
High: differences in follow up 
for intervention and control, 
baseline imbalance on vision, 
treatment fidelity unclear 
Kaluza et al. (1996, 
Germany)41 
Unclear: not 
reported 
Unclear: not 
reported 
High: blinding of 
participants 
Unclear: not 
reported who 
High: small 
sample size, low 
Unclear: 
protocol not 
High: baseline imbalances, 
possible contamination effect, 
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impossible due to 
the nature of the 
intervention 
measures 
psychological 
strain 
power, 
intention-to-
treat analysis 
unclear 
available treatment fidelity unclear 
2. Non-randomised controlled trials      
Ueda et al. (2013, 
Japan)38 
NA NA NA Unclear: unclear 
if assessors were 
blinded 
High: small 
sample size, 
drop-out was 
not reported, per 
protocol 
analysis, no 
comparison of 
the original 
groups 
Unclear: 
protocol not 
available 
High: self-selected 
participants, groups matched 
on baseline characteristics, 
possible selection bias, 
treatment fidelity unclear 
Birk et al. (2004, 
Germany)35 
NA NA NA High:  assessment 
performed by 
unmasked group 
trainer  
High: small 
sample size, low 
power, high 
drop-out (36%), 
no intention-to-
treat analysis 
Unclear: 
protocol not 
available 
Unclear: few baseline 
differences, however, analysis 
was on available cases rather 
than intention to treat, no 
specific information on 
treatment fidelity. 
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Trozzolino et al. 
(2003, USA)28 
NA NA NA Unclear: masking 
of investigator 
who obtained 
outcome not 
reported 
Low: no drop-
out 
Unclear: 
protocol not 
available 
Unclear: corrected for 
baseline differences on 
outcomes, however, treatment 
fidelity is unclear 
Evans et al. 
(1981,1982, 
USA)20,21 † 
NA NA NA Unclear: masking 
not reported 
Low: no drop-
out 
Unclear: 
protocol not 
available 
Low: the groups were well 
matched at baseline, treatment 
fidelity is partly discussed and 
maintained. 
 
3. Before and after comparisons       
Barr et al. (2014, 
UK)39  
NA NA NA High: therapists 
who offered 
intervention also 
assessed the 
outcome 
High: high 
drop-out (45%) 
Unclear: 
protocol not 
available 
High: intervention varied 
strongly between participants 
(no specific model was used), 
possible selective reporting 
and confounding 
Latham et al. 
(2013, UK)40 
NA NA NA High: assessors 
knew participants 
followed the 
intervention. 
Low: low drop-
out, 25 of 29 
starters 
provided data at 
Unclear: 
protocol not 
available 
High: Rasch analysis in small 
sample, possible confounding, 
different data collection 
methods used, treatment 
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6 months. fidelity unclear 
Alma et al. (2013, 
The Netherlands)24 
NA NA NA High: assessors 
knew participants 
followed the 
intervention 
Low: low drop 
out, 26 of 29 
starters finished 
the study 
Unclear: 
protocol not 
available 
High: missing values imputed 
by average scores, only 6 
(23%) participants attended 
all steps of the program, 
seasonal effects may have had 
an impact 
Bernbaum et al. 
(1988, 1989, 
USA)22,23 † 
NA NA NA High: research 
assistant were 
aware of 
treatment 
allocation 
Low: low drop-
out 
Unclear: no 
protocol 
available 
High: no baseline correction 
(1988), unclear why groups 
were not compared (insulin-
dependent and independent, 
1989), treatment fidelity 
unclear. 
† Articles were jointly reviewed, since they were based on the same study.  
USA United States of America, UK United Kingdom 
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Meta-analysis 
Random effect models were chosen because of high heterogeneity between the studies (I² > 
50%). Meta-regression was used to identify sources of heterogeneity in terms of study, 
intervention, control, and population characteristics. 
Depression 
A total of 16 trials (12 RCTs and 4 non-RCTs, of which two trials33,38 with two intervention 
arms that were included separately) assessed depressive symptoms. The forest plot 
demonstrated a small significant overall effect in reducing depressive symptoms in favour of 
the intervention group (SMD -0.30, 95% confidence interval (CI) -0.60 to -0.01, Figure 2A). 
The funnel plot showed one outlier,26 indicating possible publication bias (Figure 2B). Meta-
regression analysis showed that the mean age of participants partially explained heterogeneity 
across outcomes (b=0.03, 95% CI 0.01 to 0.05). Higher age of participants indicated less 
effective results (Figure 2C).  
 Anxiety 
Five trials (4 RCTs and 1 non-RCT, of which one trial38 with two intervention arms that were 
included separately) assessed anxiety symptoms. The forest plot demonstrated a medium  
overall effect in favour of the intervention group, however, this was not statistically 
significant (SMD -0.77, 95% CI -1.62 to 0.08, Figure 3A). The funnel plot indicated possible 
publication bias (Figure 3B). Meta-regression showed homogeneity in the effect size across 
the range of study, population and intervention characteristics that were investigated. 
 Psychological stress 
Four studies (3 RCTs and 1 non-RCT) assessed psychological stress. A large overall effect 
size was found in favour of the intervention group, however, this was non-significant (SMD -
1.26, 95% CI -2.78 to 0.25, Figure 4A). Meta-regression showed that the mean age of 
participants partially explained heterogeneity across outcomes (b=0.07, 95% CI 0.01 to 0.13). 
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Higher age of participants indicated less effective results (Figure 4B). An insufficient number 
of studies on this outcome were performed to produce a funnel plot.  
 Psychological well-being 
A total of 10 RCTs investigated the effect of interventions on psychological well-being; of 
these, two RCTs were excluded from the analyses because of lack of information on the 
outcomes.25,37 A non-significant overall effect in favour of the intervention group was found 
(SMD 0.30, 95% CI -0.03 to 0.63, Figure 5A) and the funnel plot indicated possible 
publication bias (Figure 5B). Again, the meta-regression analyses showed that the mean age 
of participants helped partially explain heterogeneity across outcomes (b=-0.03, 95% CI -0.05 
to -0.01), indicating that a higher age of participants resulted in less effective results (Figure 
5C).   
 Fatigue 
In two studies (1 RCT and 1 non-RCT39 with two intervention arms that were included 
separately) mental fatigue was assessed. A non-significant overall effect was found (SMD -
0.30, 95% CI -1.01 to 0.40, Figure 6), and not enough studies were found to produce a funnel 
plot. Meta-regression analyses showed homogeneity in the effect size across the range of 
study, population and intervention characteristics that were investigated. 
 Loneliness 
Since loneliness was investigated in only one study,19,20 no meta- analysis was performed on 
this outcome measure. Outcomes of this study showed a large significant effect in favour of 
the intervention group (SMD -1.36, 95% CI -1.83 to -0.88). 
 
Sensitivity analysis 
A clear outlier 26was found for the effects of interventions on depressive symptoms, anxiety 
symptoms, and psychological stress causing funnel plot asymmetry (see Figure 2B and 3B). 
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This outlier had a high effect size compared to the other studies and a high standard error 
based on a small study population (n=60). Therefore, the effect sizes on depressive symptoms, 
anxiety symptoms and psychological stress were determined without this clear outlier. After 
removal, the overall effects on depressive symptoms (SMD -0.15, 95% CI -0.31 to 0.02), 
anxiety symptoms (SMD -0.35, 95% CI -1.01 to 0.30) and psychological stress (SMD -0.16, 
95% CI -0.46 to 0.15) decreased and the effect on depressive symptoms was no longer 
significant. In addition, the mean age of participants no longer significantly explained 
heterogeneity in the outcomes on depressive symptoms (b=0.00, 95% CI -0.01 to 0.01), and 
psychological stress (b=0.01, 95% CI -0.01 to 0.03).
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Figure 2A. Forest plot of the effects of interventions on depressive symptoms (n=18). In 
Wahl et al. (2006) and Ueda et al. (2013) two different intervention arms were compared with 
one control condition. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2B. Funnel plot of the effects of interventions on depressive symptoms (n=18) 
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Figure 2C. Bubble plot of the effects of interventions on depressive symptoms versus 
mean age in years (n=18) 
 
 
 
 
 
 
 
 
 
 
Figure 3A. Forest plot of the effects of interventions on anxiety symptoms (n=6). In  Ueda 
et al. (2013) two different intervention arms were compared with one control condition.   
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Figure 3B. Funnel plot of the effects of interventions on anxiety symptoms (n=6) 
 
 
 
 
 
 
 
 
 
 
 
Figure 4A. Forest plot of the effects of interventions on psychological stress (n=4) 
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Figure 4B. Bubble plot of the effects of interventions on psychological stress versus mean 
age in years (n=4) 
 
 
 
 
 
 
 
 
 
 
 
Figure 5A. Forest plot of the effects of interventions on psychological well-being (n=7) 
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Figure 5B. Funnel plot of the effects of interventions on psychological well-being (n=7) 
 
 
 
 
 
 
 
 
 
 
 
Figure 5C. Bubble plot of the effects of interventions on psychological well-being versus 
mean age in years (n=7) 
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Figure 6. Forest plot of the effects of interventions on mental fatigue (n=3). In Ueda et al. 
(2013) two different intervention arms were compared with one control condition.  
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DISCUSSION 
To the best of our knowledge, this review is the first to systematically assess the effectiveness 
of all psychosocial interventions aimed at improving mental health in people with visual 
impairment. It shows a growing recognition of the need to address various psychological 
consequences of vision impairment. The number of studies conducted in recent years has 
increased, i.e. 18 out of 22 studies were conducted in the last decade.  
Of the 22 studies that were found, most were aimed at investigating the effects of 
interventions on depressive symptoms (n=16) and the psychological well-being of patients 
(n=10). Only a few trials investigated the effects on anxiety symptoms (n=5), psychological 
stress (n=4), mental fatigue (n=2) and loneliness (n=1). In comparison with a control 
condition, no significant overall effects on anxiety symptoms, psychological stress, mental 
fatigue and psychological well-being were found. Interventions only appeared to have a small 
significant effect on depressive symptoms (SMD -0.30, 95% CI -0.60 to -0.01), however,  
after removing a clear outlier26 this effect was also no longer significant. The outlier had a 
high risk of bias, a relatively short follow-up period (1 month), and a low age of participants 
(20 to 40 years), which may have caused the aberrant result. 
Based on the meta-regression analyses, we found no significant sources of 
heterogeneity across a range of study, intervention, control, and population characteristics, 
such as sample size, drop-out rates, study design (RCT vs. non-RCT), or interventions 
designed for people with a specific eye condition compared to people with visual impairment 
in general (different causes). In contrast to what we may have expected, interventions that 
were offered within the setting of low vision rehabilitation care (which may increase 
accessibility for those with visual impairment) were not more effective than interventions 
offered in other settings (e.g. hospital/clinical setting). In addition, we found no significant 
difference in group-based and individually offered interventions. Only the mean age of 
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participants partially explained heterogeneity in outcomes on depressive symptoms, 
psychological stress, and psychological well-being. Higher age of participants indicated 
slightly less effective results. However, after removing the previously mentioned outlier,26 the 
mean age of participants no longer significantly explained heterogeneity in the outcomes on 
depressive symptoms and psychological stress, but the influence of age on psychological 
well-being remained. Mental health problems in older adults differ from those earlier in the 
lifespan, considering presentation of the symptoms, etiology, risk and protective factors.63 
Tailoring interventions based on these differences may be essential for effective treatment of 
mental health problems in older adults with visual impairment. 
A limited number of good-quality studies was found. In several RCTs randomisation 
methods were not reported adequately. In addition, design choices (i.e. performing non-RCTs 
and BAs) often complicated possibilities for blinding assessors and induced risks of selection 
bias and confounding. Reporting bias was often unclear (in 20 out of 22 studies) because 
study protocols were missing and fidelity to the treatment protocol was often not reported. In 
addition, sample sizes were often low and follow-up periods short. Future studies should aim 
to improve the standard on research on psychosocial interventions in the field of low vision by 
performing and adequately reporting on high quality trials. 
 
Strengths and limitations 
In contrast to previous systematic reviews,9-11 all types of psychosocial interventions, offered 
in different settings, aimed at increasing mental health in people with visual impairment were 
included, and meta-regression analyses were performed to identify sources of heterogeneity 
between the studies. A large number of studies were found (i.e. 22) and current state-of-the-
art meta-analytic techniques were used. 
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 However, we also recognise a number of limitations. Due to the small number of high 
quality studies and possible publication bias (based on asymmetry in the funnel plots) it is not 
possible to draw solid conclusions regarding the benefits of psychosocial interventions on 
mental health in people with visual impairment. This is in line with the systematic review of 
Holloway et al. (2015)11 in which 6 out of 8 trials were also included in the current review15-
19, 31,32,34
 (two were not specifically aimed at improving mental health). Their conclusions on 
the effects of problem solving interventions on mental health in people with visual 
impairment were also limited due to the small number of good quality trials. In addition, a 
variety of psychosocial intervention types (e.g. self-management programmes, behavioural 
activation, PST) and a lack of homogenous outcome measures complicate the interpretation of 
the results. Furthermore, we did not include outcomes on post-traumatic-stress, suicidal 
ideation or alcohol misuse, and did not perform searches in other databases (such as the 
Cochrane Library) which may have caused us to overlook some studies. Finally, most 
questionnaires that were used in the studies were not validated in a visually impaired sample.  
 
Implications for practice and future research  
There is currently only limited evidence for the effectiveness of psychosocial interventions in 
the field of low vision. Few high quality studies, lack of homogeneity in intervention types, 
study populations and outcome measures, and possible publication bias limit conclusions that 
can be drawn. The synthesis of available evidence support the need for well-designed high 
quality studies, i.e. choosing an RCT design, which is properly powered, using proper 
randomisation methods, with blinded outcome assessment, based on trial registration and 
published study protocols, with longer follow-up measurements to investigate maintenance 
effects of interventions. The cost-effectiveness of interventions is currently completely 
lacking and should also be addressed. In addition, although anxiety symptoms, stress, mental 
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fatigue and loneliness are prevalent in people with visual impairment,1,2,4,7,8 only a few studies 
have assessed these outcomes. Therefore, more studies on interventions that address these 
problems are warranted. Finally, interventions seem to be less effective on increasing 
psychological well-being in the elderly, indicating that more attention may be needed for this 
age group in future research. 
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APPENDIX 1: Full search strategy for MEDLINE including limits 
Visual impairment 
("Visually Impaired Persons"[Mesh] OR "Vision Disorders"[Mesh] OR "Eye Diseases"[Mesh:NoExp] 
OR "Asthenopia"[Mesh] OR "Corneal Diseases"[Mesh] OR "Eye Diseases, Hereditary"[Mesh] OR "Eye 
Hemorrhage"[Mesh] OR "Eye Infections"[Mesh] OR "Cataract"[Mesh] OR "Ocular 
Hypertension"[Mesh] OR "Optic Nerve Diseases"[Mesh] OR "Retinal Diseases"[Mesh] OR ((vision 
disorder*[tiab] OR "visually impaired"[tiab] OR "visual impairment"[tiab] OR "low vision"[tiab] OR 
"visually disabled"[tiab] OR "reduced vision"[tiab] OR "subnormal vision"[tiab] OR blindness[tiab] OR 
"double vision"[tiab] OR diplopia*[tiab] OR "Hemianopsia"[tiab] OR "visual loss"[tiab] OR 
cataract[tiab] OR glaucoma[tiab] OR "macular degeneration"[tiab] OR retinopathy[tiab]) NOT 
medline[sb])) 
Mental health 
"Behavioral Symptoms"[Mesh:NoExp] OR "Depression"[Mesh] OR "Mental Fatigue"[Mesh] OR 
"Stress, Psychological"[Mesh] OR "Emotions"[Mesh] OR "Anxiety Disorders"[Mesh] OR "Mood 
Disorders"[Mesh] OR "Quality of Life"[Mesh] OR "Social Isolation"[Mesh] OR depress*[tiab] OR 
melancholia[tiab] OR dysthymi*[tiab] OR fatigue[tiab] OR tired*[tiab] OR burnout[tiab] OR stress[tiab] 
OR stressed[tiab] OR anxiety[tiab] OR fear[tiab] OR panic[tiab] OR nervous*[tiab] OR loneliness[tiab] 
OR lonely[tiab] OR lonesome[tiab] OR desolate[tiab] OR isolation[tiab] OR wellbeing[tiab] OR 
"psychological health"[tiab] OR trait[tiab] OR traits[tiab] 
Treatment 
"Rehabilitation"[Mesh] OR "Intervention Studies"[Mesh] OR "Psychotherapy"[Mesh] OR "Psychiatric 
Somatic Therapies"[Mesh] OR "prevention and control" [Subheading] OR  "Self-Help Groups"[Mesh] 
OR "Self Care"[Mesh] OR "Antidepressive Agents"[Mesh] OR "Psychiatric Status Rating 
Scales"[Mesh] OR rehabilitation[tiab] OR "self-help"[tiab] OR "self help"[tiab] OR "self-
management"[tiab] OR "self management"[tiab] OR "watchful waiting"[tiab] OR "problem solving 
treatment"[tiab] OR "problem solving therapy"[tiab] OR PST[tiab] OR CBT[tiab] OR "stepped-
care"[tiab] OR (("cognitive behavioral"[tiab] OR "cognitive behavioural"[tiab] OR Psychotherapy[tiab] 
OR intervention[tiab] OR interventions[tiab] OR training[tiab]) NOT medline[sb]) 
Adults only 
NOT (("Adolescent"[Mesh] OR "Child"[Mesh] OR "Infant"[Mesh] OR adolescen*[tiab] OR child*[tiab] 
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OR schoolchild*[tiab] OR infant*[tiab] OR girl*[tiab] OR boy*[tiab] OR teen[tiab] OR teens[tiab] OR 
teenager*[tiab] OR youth*[tiab] OR pediatr*[tiab] OR paediatr*[tiab] OR puber*[tiab]) NOT 
("Adult"[Mesh] OR adult*[tiab] OR man[tiab] OR men[tiab] OR woman[tiab] OR women[tiab] OR 
aged[tiab] OR elderly[tiab] OR senior[tiab] OR "er people"[tiab] OR "er adult"[tiab] OR "er adults"[tiab] 
OR geriatr*[tiab])) 
Publication types filter: 
NOT ("addresses"[Publication Type] OR "biography"[Publication Type] OR "comment"[Publication 
Type] OR "directory"[Publication Type] OR "editorial"[Publication Type] OR "festschrift"[Publication 
Type] OR "interview"[Publication Type] OR "lectures"[Publication Type] OR "legal cases"[Publication 
Type] OR "legislation"[Publication Type] OR "letter"[Publication Type] OR "news"[Publication Type] 
OR "newspaper article"[Publication Type] OR "patient education handout"[Publication Type] OR 
"popular works"[Publication Type] OR "congresses"[Publication Type] OR "consensus development 
conference"[Publication Type] OR "consensus development conference, nih"[Publication Type]) 
Limited to humans 
NOT (animals[mh] NOT humans[mh]) 
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APPENDIX 2: Cochrane Collaboration Risk of Bias Tool 
1. Random sequence generation (selection bias)* 
Low risk: computer random number generator, random number table or other methods were used to 
randomise participants. High risk: quasi-random methods were used.  
2. Allocation concealment (selection bias)* 
Low risk: sequence of allocation was concealed, for example by using central allocation and sealed 
envelopes. High risk: sequence of allocation was knwon, for example by staff. 
3. Blinding of participants and personnel (performance bias)* 
Low risk: participants and staff were masked and it was unlikely that masking could have been broken. 
Or there was no masking or incomplete masking, but it would be unlikely that the outcomes were 
influenced. High risk: one or both criteria were not met. 
4. Blinding of outcome assessment (detection bias) 
Low risk: assessors were masked (e.g. participants were asked not to reveal their allocation). Or assessors 
were not masked (for example in non-RCTs), but the outcome was unlikely to be influenced. High risk: 
one or both criteria were not met.  
5. Incomplete outcome data addressed (attrition bias) 
Low risk: no or limited missing data, follow-up rates and compliance were similar in groups, reasons for 
missing data were not related to the outcome and intention-to-treat analysis was performed. High risk: 
imbalances in numbers or reasons for missings between groups, probabale that missing data would 
change the outcome, or per-protocol analyses were performed.  
6. Selective outcome reporting (reporting bias)  
Low risk: trial registration or study protocol was available and all pre-specified outcomes (of interest to 
this review) were reported. High risk: pre-specified outcomes were not or incompletely reported.  
7. Other bias  
Low risk: the study appeared to be free of other sources of risk. High risk: issues specific to study design, 
such as cross-over designs or cluster randomization, or considerable baseline imbalances on the 
outcomes or important participant characteristics, or lack of fidelity to the treatment protocol 
* Not asssessed for non- randomised controlled trials (RCTs) and before and after comparisions (BAs), because 
the chosen designs do not allow meeting these requirements. 
 
